June 8, 2026 - 04:54

Campbell's Company is set to release its fiscal third-quarter earnings on Monday, with Wall Street closely watching for any indication that its snack division is turning a corner. After a challenging first half of the fiscal year, investors are eager to see if the company's efforts to stabilize the segment are gaining traction.
The snack business, which includes brands like Goldfish crackers and Pepperidge Farm cookies, has been under pressure from shifting consumer habits and higher ingredient costs. Shoppers have been trading down to cheaper store brands or cutting back on discretionary snacks altogether, squeezing margins for packaged food giants.
Analysts expect Campbell's to report modest revenue growth, driven largely by its soup and meal division, which has remained resilient. However, the real focus will be on the snack segment's performance. Any signs of volume recovery or improved pricing power could boost confidence in the company's long-term outlook.
Campbell's has been investing in product innovation and marketing to revive snack sales, but the broader economic environment remains uncertain. With inflation still weighing on household budgets, the company may need to show more than just incremental progress to satisfy investors.
The earnings call on Monday will likely provide clues on whether the worst is over for the snack business or if more headwinds lie ahead.
July 22, 2026 - 17:45
Well-known cardiologist named chief medical officer of wearable tech company WhoopAmi B. Bhatt, MD, a prominent cardiologist known for her work in digital health, has been appointed as the new chief medical officer of Whoop, the wearable technology company. Bhatt steps down from...
July 22, 2026 - 11:53
Insurers cut prices in hunt for new oil and gas businessA surge in competition among insurance firms is driving down premiums for oil and gas projects located in politically stable regions, as underwriters aggressively pursue new business. Industry...
July 21, 2026 - 19:05
Novo Nordisk sues GLP-1 rival Eli Lilly over claims of false advertisingNovo Nordisk has filed a lawsuit against Eli Lilly, accusing the pharmaceutical giant of running advertisements that are `false and materially misleading.` The legal complaint centers on marketing...
July 21, 2026 - 10:09
Dimitri de Vreeze helped build DSM’s materials business. Then he had to sell itAfter more than 30 years at the science-based company DSM, Dimitri de Vreeze faced what he calls the hardest decision of his career. He had to sell the materials division, the very unit where he...